安徽医学
安徽醫學
안휘의학
ANHUI MEDICAL JOURNAL
2015年
6期
701-703,704
,共4页
段伟%徐艳秋%李小波%邵明学
段偉%徐豔鞦%李小波%邵明學
단위%서염추%리소파%소명학
主动脉内球囊反搏%急性冠脉综合征%N末端B型利钠肽原%超敏C反应蛋白%左心室射血分数
主動脈內毬囊反搏%急性冠脈綜閤徵%N末耑B型利鈉肽原%超敏C反應蛋白%左心室射血分數
주동맥내구낭반박%급성관맥종합정%N말단B형리납태원%초민C반응단백%좌심실사혈분수
Intra-aotric balloon pump%Acute coronary syndrome%N-terminal pro-B-type natriuretic peptide%Hypersensitive C-reac-tive protein%Left ventricular ejection fraction
目的:评价主动脉内球囊反搏术( IABP)辅助经皮冠状动脉介入( PCI)治疗高危急性冠脉综合征( ACS)患者的效果。方法选取95例ACS合并血流动力学不稳定或心源性休克的高危患者并分为两组,50例患者PCI前24 h内进行IABP治疗(IABP+PCI组),45例直接PCI(PCI组)。在入院及PCI术后第5天分别检测N末端B型利钠肽原(NT-proBNP)和超敏C反应蛋白( hs-CRP)水平;入院时及出院后4周心脏彩超测定左心室射血分数( LVEF)。结果治疗前两组收缩压均偏低,两组差异无统计学意义(P>0.05)。治疗后,IABP+PCI组血压较PCI组血压明显升高(P<0.05);同时IABP+PCI组病死率有所下降(P<0.05),住院天数减少(P<0.05)。两组治疗前的血浆NT-proBNP和hs-CRP差异无统计学意义(P>0.05),治疗后IABP+PCI组血浆NT-proBNP 和 hs-CRP水平较PCI组明显下降(P<0.05),LVEF明显提高(P<0.05)。结论 IABP辅助PCI治疗高危ACS患者,在一定程度上改善了血流动力学,并使住院天数和短期病死率有所下降,同时降低了血浆NT-proBNP 和 hs-CRP水平,提高了LVEF。
目的:評價主動脈內毬囊反搏術( IABP)輔助經皮冠狀動脈介入( PCI)治療高危急性冠脈綜閤徵( ACS)患者的效果。方法選取95例ACS閤併血流動力學不穩定或心源性休剋的高危患者併分為兩組,50例患者PCI前24 h內進行IABP治療(IABP+PCI組),45例直接PCI(PCI組)。在入院及PCI術後第5天分彆檢測N末耑B型利鈉肽原(NT-proBNP)和超敏C反應蛋白( hs-CRP)水平;入院時及齣院後4週心髒綵超測定左心室射血分數( LVEF)。結果治療前兩組收縮壓均偏低,兩組差異無統計學意義(P>0.05)。治療後,IABP+PCI組血壓較PCI組血壓明顯升高(P<0.05);同時IABP+PCI組病死率有所下降(P<0.05),住院天數減少(P<0.05)。兩組治療前的血漿NT-proBNP和hs-CRP差異無統計學意義(P>0.05),治療後IABP+PCI組血漿NT-proBNP 和 hs-CRP水平較PCI組明顯下降(P<0.05),LVEF明顯提高(P<0.05)。結論 IABP輔助PCI治療高危ACS患者,在一定程度上改善瞭血流動力學,併使住院天數和短期病死率有所下降,同時降低瞭血漿NT-proBNP 和 hs-CRP水平,提高瞭LVEF。
목적:평개주동맥내구낭반박술( IABP)보조경피관상동맥개입( PCI)치료고위급성관맥종합정( ACS)환자적효과。방법선취95례ACS합병혈류동역학불은정혹심원성휴극적고위환자병분위량조,50례환자PCI전24 h내진행IABP치료(IABP+PCI조),45례직접PCI(PCI조)。재입원급PCI술후제5천분별검측N말단B형리납태원(NT-proBNP)화초민C반응단백( hs-CRP)수평;입원시급출원후4주심장채초측정좌심실사혈분수( LVEF)。결과치료전량조수축압균편저,량조차이무통계학의의(P>0.05)。치료후,IABP+PCI조혈압교PCI조혈압명현승고(P<0.05);동시IABP+PCI조병사솔유소하강(P<0.05),주원천수감소(P<0.05)。량조치료전적혈장NT-proBNP화hs-CRP차이무통계학의의(P>0.05),치료후IABP+PCI조혈장NT-proBNP 화 hs-CRP수평교PCI조명현하강(P<0.05),LVEF명현제고(P<0.05)。결론 IABP보조PCI치료고위ACS환자,재일정정도상개선료혈류동역학,병사주원천수화단기병사솔유소하강,동시강저료혈장NT-proBNP 화 hs-CRP수평,제고료LVEF。
Objective To evaluate the efficacy of intra-aortic balloon pump( IABP) as an adjunct to percutaneous coronary interven-tion( PCI) for high-risk acute coronary syndromes( ACS) patients. Methods Ninety five high-risk ACS patients with unstable hemodynamic or cardiogenic shock who underwent PCI were divided into two groups, 50 patients were treated with IABP within 24 hours before PCI ( IABP+PCI group) , and 45 patients with PCI only ( PCI group) . Plasma NT-proBNP and hs-CRP were measured on the first day during hospitali-zation and fifth day after PCI. Left ventricular ejection fraction( LVEF) was measured by echocardiography on the first day during hospitaliza-tion, and 4 weeks after discharge. Results SBP of the two groups was low before the treatment, with no significant difference between the two groups(P>0. 05). After the treatment, SBP was significantly higher in the patients underwent PCI with IABP support compared with control group(P<0. 05). Moreover, undergoing PCI with IABP support could decrease the short-time mortality(P<0. 05), and decrease the hospitalization days (P<0. 05). NT-proBNP and hs-CRP of the two groups were increased at the beginning of the treatment, but there was no significant difference between the two groups (P>0. 05). After the treatment, NT-proBNP and Hs-CRP decreased and LVEF increased more significantly in IABP group (P<0. 05). Conclusion For high-risk patients with unstable hemodynamics or cardiogenic shock, PCI with IABP support could improve hemodynamics to a certain extent and decrease hospitalization days and the short-time mortality;PCI with IABP support could also decrease plasma NT-proBNP, hs-CRP, and LVEF.